<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Incidence of Single-Drug Resistant-, Multidrug- Resistant, and Extensively Drug- Resistant Escheria Coli Urinary Tract Infections: An Australian Laboratory-Based Retrospective Study

avondale-bepress.context-key13297352
avondale-bepress.submission-pathnh_papers/177
avondale.affiliateMitchell, Brett; 0000-0003-4220-8291
avondale.departmentLifestyle Medicine and Health Research Centre
avondale.facultyNursing
avondale.reporting.isPeerReviewedPeer Reviewed
avondale.reporting.versionPublished Version
dc.contributor.authorGardner, Anne
dc.contributor.authorCollignon, Peter
dc.contributor.authorMitchell, Brett G.
dc.contributor.authorMnatzaganian, George
dc.contributor.authorDas, Anindita
dc.contributor.authorFasugba, Oyebola
dc.date.accessioned2023-11-01T00:27:54Z
dc.date.available2023-11-01T00:27:54Z
dc.date.issued2019-03-01
dc.date.submitted2018-11-12T18:32:36Z
dc.description.abstract<p><h3 id="x-x-x-x-x-x-x-x-x-x-x-sect0015">Objectives</h3> <p id="x-x-x-x-x-x-x-x-x-x-x-spar0035">To evaluate incidence of single-drug resistant, multidrug-resistant, extensively drug-resistant and pandrug-resistant <em>E. coli</em> urinary tract infections (UTI) in a sample of Australian Capital Territory (ACT) residents. <h3 id="x-x-x-x-x-x-x-x-x-x-x-sect0020">Methods</h3> <p id="x-x-x-x-x-x-x-x-x-x-x-spar0040">We utilised laboratory-based retrospective data from all ACT residents whose urine samples were processed from January 2009 to December 2013. Multivariate logistic regression models were constructed to determine the associations of age, sex, urine sample source and socioeconomic status with risk of resistant infections. <h3 id="x-x-x-x-x-x-x-x-x-x-x-sect0025">Results</h3> <p id="x-x-x-x-x-x-x-x-x-x-x-spar0045">A total of 146,915 urine samples from 57,837 ACT residents were identified over five years. Mean age of people in the sample was 48 years (standard deviation = 26 years) and 64.4% were females. Five-year incidence of single-drug resistant <em>E. coli</em> UTI was high for ampicillin, trimethoprim and cefazolin (6.8%, 3.5% and 1.9% respectively). No pandrug-resistant <em>E. coli</em> UTI was detected. Five-year incidences of multidrug- and extensively drug-resistant <em>E. coli</em> UTI were 1.9% and 0.2% respectively, which is low in comparison to international rates. Female sex and age over 38 years were significantly associated with single- and multidrug-resistance. Compared to hospitals, office-hours general practices, community and specialist health services, risk of single-drug resistance was significantly higher in samples from after-hours general practices (adjusted-odds ratio (OR) and 95% confidence intervals (CI) 2.6 (2.2–3.1)). <h3 id="x-x-x-x-x-x-x-x-x-x-x-sect0030">Conclusions</h3> <p id="x-x-x-x-x-x-x-x-x-x-x-spar0050">Our findings have significant implications for antimicrobial prescribing given identified risk factors for the detection of resistance, especially in patients attending after-hours general practices.</p>
dc.identifier.citation<p>Fasugba, O., Das, A., Mnatzaganian, G., Mitchell, B., Collignon, P., & Gardner, A. (2019). Incidence of single-drug resistant, multidrug- resistant, and extensively drug-resistant <em>Escherichia coli</em> urinary tract infections: An Australian laboratory-based retrospective study. <em>Journal of Global Antimicrobial Resistance, 16</em>, 254-259. doi:10.1016/j.jgar.2018.10.026</p>
dc.identifier.doihttps://doi.org/10.1016/j.jgar.2018.10.026
dc.identifier.issn2213-7165
dc.identifier.urihttps://research.avondale.edu.au/handle/1897/13297352
dc.language.isoen_us
dc.provenance<p>This article was originally published as:</p> <p>Fasugba, O., Das, A., Mnatzaganian, G., Mitchell, B., Collignon, P., & Gardner, A. (2019). Incidence of single-drug resistant, multidrug- resistant, and extensively drug- resistant <em>Escherichia coli</em> urinary tract infections: An Australian laboratory-based retrospective study. <em>Journal of Global Antimicrobial Resistance</em>, 16(1), 254-259. doi:10.1016/j.jgar.2018.10.026</p>
dc.relation.ispartofJournal of Global Antimicrobial Resistance
dc.rights<p>&copy; 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.</p> <p>This article may be accessed from the publisher <a href="https://doi.org/10.1016/j.jgar.2018.10.026">here.</a></p>
dc.subjectantimicrobial resistance; Escherichia coli; urinary tract infection; incidence
dc.titleIncidence of Single-Drug Resistant-, Multidrug- Resistant, and Extensively Drug- Resistant Escheria Coli Urinary Tract Infections: An Australian Laboratory-Based Retrospective Study
dc.typeJournal Article

Files

Avondale University acknowledges our Sovereign God as Creator and Provider of all things. We respectfully acknowledge the Awabakal and Darramuragal people as the traditional custodians of the lands on which we live, work, study and worship across our Lake Macquarie and Sydney campuses. We pay our respects to Elders past, present and emerging, and extend that respect to all First Nations People.

Aboriginal Peoples are advised the Library Collection contains images, voices and names of deceased people in physical and online resources. The Library recognises the significance of the traditional cultural knowledges contained within its Collection. The Library acknowledge some materials contain language that may not reflect current attitudes, was published without consent or recognition, or, is offensive. These materials reflect the views of the authors and/or the period in which they were produced and do not represent the views of the Library.

Avondale University is a member of the worldwide Seventh-day Adventist system of universities and colleges.

CRICOS Provider No.: 02731D. RTO: 91191. TEQSA: PRV12015. ABN: 53 108 186 401.

© Avondale University Ltd 2026